Experimental studies on the different route of gene transfer of rAAV-VEGF_(165)into ischemic rat brain to affect the angiogenesis in the ischemic penumbra in rats
Xuejun Fu
Abstract
Xuejun Fu
Abstract
Objective To investigate the effect of recombinant adeno-associated virus mediated vascular en-dothelial growth factor 165 gene (rAAV-VEGF165) on angiogenesis in the ischemic penumbra in rats by cere-brospinal fluid (CSF) or intravenous route. Methods After establishing a rat model of permanent middle cerebral artery occlusion (MACO) by nylon suture embolization and cerclage,the rAAV-VEGF165gene was injected through CSF or intravenous in 24 hours. On the 7th and 14th day,the rats were killed,microvessel density was assessed with CD34 immunohistochemistry. Results The density of CD31-IR-positive cell (under high power field, ×200) in the cerebral ischemic penumbra of each group at the 7th day was 92. 73±5. 18 in CSF group, 77. 40±5. 43 in intravenous group,46. 50±5. 33 in MCAO group and 13. 90±1. 49 in sham-operation group respectively(P0. 05)s and at the 14th day was 104. 05±4. 30 in CSF group,89. 88 ± 5. 77 in intravenous group,65. 33 ± 2. 31 in MCAO group and 13. 08±1. 90 in sham-operation group respectively(P0. 05). Conclusion The rAAV-VEGF165 can be transfected into the cerebral ischemic tissue through both CSF route and intravenous route to express VEGF,which can promote the formation of new vessels and protect neurocytes in cerebral ischemic disease.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of recombinant adeno-associated virus mediated vascular en-dothelial growth factor 165 gene (rAAV-VEGF165) on angiogenesis in the ischemic penumbra in rats by cere-brospinal fluid (CSF) or intravenous route. Methods After establishing a rat model of permanent middle cerebral artery occlusion (MACO) by nylon suture embolization and cerclage,the rAAV-VEGF165gene was injected through CSF or intravenous in 24 hours. On the 7th and 14th day,the rats were killed,microvessel density was assessed with CD34 immunohistochemistry. Results The density of CD31-IR-positive cell (under high power field, ×200) in the cerebral ischemic penumbra of each group at the 7th day was 92. 73±5. 18 in CSF group, 77. 40±5. 43 in intravenous group,46. 50±5. 33 in MCAO group and 13. 90±1. 49 in sham-operation group respectively(P0. 05)s and at the 14th day was 104. 05±4. 30 in CSF group,89. 88 ± 5. 77 in intravenous group,65. 33 ± 2. 31 in MCAO group and 13. 08±1. 90 in sham-operation group respectively(P0. 05). Conclusion The rAAV-VEGF165 can be transfected into the cerebral ischemic tissue through both CSF route and intravenous route to express VEGF,which can promote the formation of new vessels and protect neurocytes in cerebral ischemic disease.
Key concepts: Penumbra, Angiogenesis, Medicine, CD31, Vascular endothelial growth factor, CD34, Ischemia, Immunohistochemistry